Plasma and Brain Levels of Oxindole in Experimental Chronic Hepatic Encephalopathy: Effects of Systemic Ammonium Acetate and L‐Tryptophan

: It has previously been shown that the neurodepressant L‐tryptophan metabolite oxindole is increased in the blood and brain of rats with fulminant hepatic failure and in the blood of cirrhotic patients affected by chronic hepatic encephalopathy. In the present investigation, we found that oxindole...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacology & toxicology 1999-11, Vol.85 (5), p.138-143
Main Authors: Bergqvist, Peter B. F., Carpenedo, Raffaella, Apelqvist, Gustav, Moroni, Flavio, Bengtsson, Finn
Format: Article
Language:English
Subjects:
Acetates - pharmacology
Administration, Oral
Animals
Biological and medical sciences
Brain - drug effects
Brain - metabolism
Disease Models, Animal
Drug toxicity and drugs side effects treatment
Hepatic Encephalopathy - blood
Hepatic Encephalopathy - etiology
Indoles - blood
Injections, Intraperitoneal
Liver - drug effects
Liver - metabolism
Liver - surgery
Male
Medical sciences
MEDICIN
MEDICINE
Oxindoles
Pharmacology. Drug treatments
Portacaval Shunt, Surgical
Rats
Rats, Sprague-Dawley
Toxicity: nervous system and muscle
Tryptophan - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:: It has previously been shown that the neurodepressant L‐tryptophan metabolite oxindole is increased in the blood and brain of rats with fulminant hepatic failure and in the blood of cirrhotic patients affected by chronic hepatic encephalopathy. In the present investigation, we found that oxindole levels were significantly increased in the blood and brain of portacaval‐shunted rats, an animal model of chronic hepatic encephalopathy, compared with sham‐operated controls. A further increase in plasma and brain oxindole content was found after oral administration of L‐tryptophan (300 mg/kg) to both portacaval‐shunted or sham‐operated animals, while intraperitoneal injection of the amino acid did not modify oxindole content either in brain or blood. Ammonium acetate administration (4.0 mmol/kg, intraperitoneal) reversibly deteriorated the neurological status of portacaval‐shunted animals, but did not modify, in a directly related manner, plasma and brain oxindole content. The present findings are in line with the possibility that oxindole may be an additional L‐tryptophan‐related candidate in the pathogenesis of chronic hepatic encephalopathy.
ISSN:0901-9928
1600-0773
1600-0773
DOI:10.1111/j.1600-0773.1999.tb00081.x